NCATS will fund up to $400,000 for projects that develop 3D-bioprinted tissue models for drug discovery, including efficacy studies and toxicology research through a collaborative arrangement between the 3-D Bioprinting Program at NCATS and other scientists.

NCATS scientists will provide expertise for 3-D bioprinting, assay development, and drug screening stages of the projects. Other investigators will provide appropriate cell resources, disease expertise, and model validation to perform drug screening of bioprinted materials.

Learn more and submit your application here.